source
- FDA issues new guidances on adhesive performance and skin irritation testing for generic transdermal drugsThe U.S. Food and Drug Administration has released two new guidances that address transdermal and topical delivery systems for generic drugs. One guidance, issued as final, focuses on how manufact…
- BioNTech appoints Sobi's Guido Oelkers as new CEO, to start by Feb 1 2027BioNTech announced that Guido Oelkers, currently a leader at Swedish biotech company Sobi, will become its next chief executive officer. Oelkers is expected to take over the role no later than Feb…